Cereal killer: EFSA rejects Nestlé’s beta-glucan health claim

Related Articles

FormattedPicture

BUSINESS NEWS

Nestlé could be potentially divesting its peanut allergy treatment Palforzia following slower than expected adoption by patients and healthcare professionals.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nestlé has revealed that from next July it will globally ban all marketing for children below 16 years of age on certain high-sugar products. Meanwhile, a... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Nestlé scientists have discovered a new gut bacteria prevalent during the transition from infancy to early childhood. The discovery is said to enable the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

A pioneering study has produced novel insights into how brain metabolism relates to motivation levels in humans. Conducted by the École Polytechnique... Read More

FormattedPicture

BUSINESS NEWS

Perrigo has acquired Nestlé’s gateway infant formula plant in Wisconsin, US, and purchased US and Canadian rights to the Nestlé-owned Good Start... Read More

trans